Shubham Misra: CCL2 As a Potential Biomaker for Post-Stroke Seizures, Epileptiform Discharges and Mortality
Shubham Misra, Postdoctoral Associate at Yale Department of Neurology, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Our latest study, published in PLOS One, identifies the role of CCL2 as a potential biomarker associated with late seizures and epileptiform discharges (SED) and 90-day mortality post SED in ICH patients.”
Title: Characterizing inflammatory biomarkers in post-stroke seizure risk and outcome prognostication
Authors: Ethan Y. Wang, Shubham Misra, Jennifer Yan, Pei Yi Chook, Yuki Kawamura, Rachel Kitagawa, Jennifer A. Kim, Emily J. Gilmore, Adam de Havenon, Adithya Sivaraju, Lawrence J. Hirsch, Guido J. Falcone, Srikant Rangaraju, Lauren H. Sansing, Jessica Magid-Bernstein, Nishant K. Mishra
Read the Full Article on PLOS One
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 21, 2026, 12:42Moustafa Abdou: Diagnosis and Management of Pyruvate Kinase Deficiency
-
Aug 21, 2026, 12:38Luluva Ghadiyali: Modern Approaches to Aplastic Anemia
-
Aug 21, 2026, 12:34Kellie Machlus: Animal Models Driving Progress in Thrombosis Research
-
Aug 21, 2026, 12:08Amy Allen Whitfield: Helping to Proceed Bleeding Disorders Care
-
Aug 21, 2026, 11:53Jan Terje Andersen: Harnessing Placental Biology for Therapeutic Engineering
-
Aug 21, 2026, 11:02Severe ITP, Critical Bleeding, and the Challenge of Platelet Testing – RPTH Journal
-
Aug 21, 2026, 10:46Arwa Z. Al-Riyami: Looking Ahead to ISBT Muscat 2029
-
Aug 21, 2026, 10:42Janine Mothershed: What Is Romiplostim and How Does It Work in Immune Thrombocytopenia?
-
Aug 21, 2026, 10:33Omar Alkharabsheh: Excited to Build the Future of Hematologic Malignancy Care in Central Florida